Stockscreener 앱 받기
4.94
1.23%
0.06
Bio Green Med Solution Inc 주식(BGMS)의 최신 뉴스
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bio Green Med Solution Appoints New Independent Director - TipRanks
Cyclacel Pharmaceuticals: Recent Acquisition Completed - MSN
Bio Green Med Solution Faces Nasdaq Delisting Notice - TipRanks
BlackRock® Canada Announces Product Changes - The Manila Times
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period - The Manila Times
Bio Green Med Solution announces closing of strategic acquisition of Fitters Sdn. Bhd. - MarketScreener
Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative
Major Shareholder Cashes Out Big on Cyclacel Pharmaceuticals! - TipRanks
Cyclacel Pharmaceuticals Approves Key Shareholder Proposals - TipRanks
Cyclacel Pharmaceuticals shareholders approve share issuance and name change - Investing.com
Cyclacel Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Cyclacel Pharmaceuticals to Implement 1-for-15 Reverse Stock Split; Shares Fall - MarketScreener
Cyclacel Pharmaceuticals, Inc. announced that it has received $3 million in funding - MarketScreener
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT - MarketScreener
Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve
Wacker Buys Manufacturing Assets and Know-how of Bio Med Sciences - CHEManager
Cyclacel Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - MarketScreener
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - MarketScreener
Roth MKM Downgrades Cyclacel Pharmaceuticals(CYCC.US) to Hold Rating - 富途牛牛
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - MarketScreener
WACKER Positions itself as Solution Provider for Silicone-Coated Healthcare Products with New Acquisition - PR Newswire
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results - MarketScreener
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO and Investor Conference - MarketScreener
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer - MarketScreener
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update - MarketScreener
Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit - MarketScreener
Alaunos Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TCRT - Benzinga
Waste biorefinery towards a sustainable circular bioeconomy: a solution to global issues - Biotechnology for Biofuels and Bioproducts
Cyclacel Pharmaceuticals Announces Management Changes - MarketScreener
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures - MarketScreener
Cyclacel Pharmaceuticals to Present at the Noble Capital Markets Investor Conference - MarketScreener
2.36%
1.10%
자본화:
|
볼륨(24시간):